|
1）厚生労働省．平成24年人口動態統計（確定数）の概況死因簡単分類別にみた性別死亡数・死亡率．http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei12/dl/11_h7.pdf
|
|
|
|
|
2）日本呼吸器学会COPDガイドライン第4版作成委員会，編．第III章 治療と管理 2．薬物療法．COPD診断と治療のためのガイドライン 第4版．東京：メディカルレビュー社；2013. p.66-71
|
|
|
|
|
|
3）Fishman A, Martinez F, Naunheim K, et al. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003; 348: 2059-73
|
|
|
|
|
4）Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med. 2011; 184: 159-71
|
|
|
|
|
|
5）Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med. 1997; 3: 675-7
|
|
|
|
|
|
6）Yuhgetsu H, Ohno Y, Funaguchi N, et al. Beneficial effects of autologous bone marrow mononuclear cell transplantation against elastase-induced emphysema in rabbits. Exp Lung Res. 2006; 32: 413-26
|
|
|
|
|
|
7）Shigemura N, Sawa Y, Mizuno S, et al. Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats. Circulation. 2005; 111: 1407-14
|
|
|
|
|
|
8）Murakami S, Nagaya N, Itoh T, et al. Adrenomedullin regenerates alveoli and vasculature in elastase-induced pulmonary emphysema in mice. Am J Respir Crit Care Med. 2005; 172: 581-9
|
|
|
|
|
|
9）Morino S, Nakamura T, Toba T, et al. Fibroblast growth factor-2 induces recovery of pulmonary blood flow in canine emphysema models. Chest. 2005; 128: 920-6
|
|
|
|
|
|
10）Mori N, Gotoh M, Chang SS, et al. Reconstruction of emphysematous lung tissue using slowly released basic fibroblast growth factor from gelatin microspheres. ASAIO J. 2008; 54: 622-6
|
|
|
|
|
|
11）Stolk J, Stockley RA, Stoel BC, et al. Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor. Eur Respir J. 2012; 40: 306-12
|
|
|
|
|
|
12）Weiss DJ, Casaburi R, Flannery R, et al. A placebo-controlled randomized trial of mesenchymal stem cells in chronic obstructive pulmonary disease. Chest. 2013; 143: 1590-8
|
|
|
|
|
|
13）Butler JP, Loring SH, Patz S, et al. Evidence for adult lung growth in humans. N Engl J Med. 2012; 367: 244-7
|
|
|
|
|
|
14）Mizobuchi T, Chen F, Yoshino I, et al. Radiologic evaluation for volume and weight of remnant lung in living lung donors. J Thorac Cardiovasc Surg. 2013; 146: 1253-8
|
|
|
|
|
|
15）Ishibashi Y, Harada S, Takemura T, et al. Clinical effect of KCB-1 (bFGF) in patients with skin ulcer in the 12 weeks administration. Rinsho-Iyaku. 1996; 12: 2117-29
|
|
|
|
|
|
16）Ichioka S, Ohura N, Nakatsuka T. The positive experience of using a growth factor product on deep wounds with exposed bone. J Wound Care. 2005; 14: 105-9
|
|
|
|
|
|
17）Bikfalvi A, Klein S, Pintucci G, et al. Biological roles of fibroblast growth factor-2. Endocr Rev. 1997; 18: 26-45
|
|
|
|
|
|
18）田畑泰彦．バイオマテリアルからみた再生誘導治療．人工臓器．2009; 38: 8-11
|
|
|
|
|
19）Kinoshita T, Miyoshi S, Katoh M, et al. Intrapleural administration of a large amount of diluted fibrin glue for intractable pneumothorax. Chest. 2000; 117: 790-5
|
|
|
|
|
|
20）Kinoshita T, Miyoshi S, Suzuma T, et al. Intrapleural administration of a large amount of diluted fibrin glue for intractable pneumothorax. A clinical study based on 57 cases: including 2 unsuccessful cases. Jpn J Thorac Cardiovasc Surg. 2003; 51: 41-7
|
|
|
|
|
|
21）Kawago M, Yoshimasu T, Tabata Y, et al. Intrapleural administration of gelatin-embedded, sustained-release basic fibroblast growth factor for the regeneration of emphysematous lungs in rats. J Thorac Cardiovasc Surg. 2014; 147: 1644-9
|
|
|
|
|